re: Ann: Invion announces Rights Issue Entitl... W27, agree to some extent-but why would you even sell if you could not to participate in the offer.( Iam aware everyone's finicial circumstances are diffeent).As analysts and Invion have predicted an early partnering opportunity with a major pharma,obviously this is not going to happen without positive results,so I presume Invion is quietly confident.Yourself and I know that IV worked very effectively, and probably more so with the doses prescribed at higher levels for this Lupus trial.
If you currently had 100000 shares and sold at today's close of 7.9 c you have $7900.00.If you waited and sold at say 20c(very low estimate) in say several months time you have $20K--big difference .
Keep in mind we are only talking about those who will not be subscribing to this offer.If you are a trader I would not think there are to many stocks at the moment that may give you this sort of return.
- Forums
- ASX - By Stock
- Ann: Invion announces Rights Issue Entitlement Of
IVX
invion limited
Add to My Watchlist
4.00%
!
13.0¢

re: Ann: Invion announces Rights Issue Entitl... W27, agree to...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
13.0¢ |
Change
0.005(4.00%) |
Mkt cap ! $11.01M |
Open | High | Low | Value | Volume |
12.5¢ | 13.5¢ | 12.5¢ | $36.56K | 283.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 247400 | 12.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
13.0¢ | 119856 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 247400 | 0.120 |
3 | 245489 | 0.115 |
1 | 49800 | 0.110 |
3 | 20320 | 0.105 |
5 | 53300 | 0.100 |
Price($) | Vol. | No. |
---|---|---|
0.130 | 119856 | 1 |
0.135 | 20000 | 1 |
0.140 | 22292 | 2 |
0.145 | 32000 | 1 |
0.150 | 146065 | 4 |
Last trade - 15.40pm 23/06/2025 (20 minute delay) ? |
Featured News
IVX (ASX) Chart |